03726nam 22005652 450 991095699300332120251114022137.09789815011425981501142110.1355/9789815011425(MiAaPQ)EBC6893958(Au-PeEL)EBL6893958(CKB)21325726900041(OCoLC)1299382353(MdBmJHUP)musev2_101462(DE-B1597)652371(DE-B1597)9789815011425(UkCbUP)CR9789815011425(Perlego)4196096(UkCbUP)CR9789815011418(EXLCZ)992132572690004120230804d2023|||| uy| 0engur|||||||||||txtrdacontentcrdamediacrrdacarrier'Building a Sailboat in a Storm' The Evolution of COVAX in 2021 and its Impact on Supplies to Southeast Asia's Six Lower-Income Economies /Khairulanwar ZainiFirst edition.Singapore :ISEAS–Yusof Ishak Institute,2023.1 online resource digital, PDF file(s)Trends in Southeast Asia ;issue 4, 2022Title from publisher's bibliographic system (viewed on 14 Nov 2025).9789815011418 9815011413 Frontmatter -- FOREWORD -- EXECUTIVE SUMMARY -- INTRODUCTION -- HOW THE “BEAUTIFUL IDEA” OF COVAX FALTERED -- COVAX’S FIRST PHASE: AN “ABYSMAL FAILURE” FOR THE AMC6 IN 1H 2021 -- COVAX’S SECOND PHASE: THE PIVOT TO DOSE DONATIONS -- THE AMC6’S BURGEONING COVAX SUPPLY IN 2H -- W(H)ITHER COVAX 2.0? -- COVAX 2.0: A BOON WITH HIDDEN COSTS AND CONSEQUENCES?In the first half of 2021, COVID-19 vaccine doses from the COVAX Facility were in short supply, and the plan to mass produce COVAX vaccines through the Serum Institute of India (SII) faltered as the pandemic surged in India in March 2021. Due to COVAX's shift in approach towards convincing richer nations to redistribute their excess doses, the second half of 2021 saw increases in the frequency and volume of its shipments. Donors were however able to 'earmark' their dose donations and identify their intended recipients. The six Southeast Asian countries which qualified for free COVAX shots - Cambodia, Indonesia, Laos, the Philippines, Timor-Leste and Vietnam (the AMC6) - received 16 million doses in the first half of 2021. In the second half, they received 128 million doses from COVAX, 80.9 per cent of which were earmarked donations. Despite making up 7 per cent of the world population, the AMC6 collectively accounted for 24.3 per cent of all earmarked dose donations (and 25 per cent of the United States' total dose donations) to COVAX in 2021. The AMC6 greatly benefitted from COVAX's pivot to dose donations. This demonstrated the region's strategic salience to Washington and its allies, but came at the expense of vaccine equity, which the region has prudential reasons to care about. The execution of COVAX hammers home the hard truth that multilateral governance is a difficult act to pull off even with the best intentions and is not impervious to the geopolitical interests and agendas of the major powers.Trends in Southeast Asia ;issue 4, 2022.Drug accessibilitySoutheast AsiaDrug accessibilityDrug accessibilityDrug accessibility.362.1969792Khairulanwar Zaini1861384UkCbUPUkCbUPBOOK9910956993003321Building a Sailboat in a Storm4467467UNINA05328oam 2200505zu 450 991097391900332120251117110658.0(CKB)2670000000545600(SSID)ssj0001133633(PQKBManifestationID)12453177(PQKBTitleCode)TC0001133633(PQKBWorkID)11157553(PQKB)10474862(MiAaPQ)EBC3386947(BIP)41321643(EXLCZ)99267000000054560020160829d2013 uy engurcnu||||||||txtccrCurrent vascular surgery 2012[Place of publication not identified]People's Medical Pub House USA20131 online resource (532 pages)Bibliographic Level Mode of Issuance: Monograph1-60795-175-4 Intro -- Preface -- Acknowledgments -- Contents -- Contributors -- Section I Cerebrovascular Disease -- 1 Interviews of Leaders andContributors in VascularSurgery -- 2 Effects of Age on CASResults: Data from CREST -- 3 Trans-cervical CarotidStenting with Carotid FlowReversal for CerebralProtection -- 4 Early CEA After Stroke -- 5 Cognitive Changes After Carotid Endarterectomy and Carotid Artery Stenting -- Section II Supra-aortic Trunk Disease -- 6 Current Management of Acute Spontaneous Carotid Dissections -- 7 Effects of Renal Disease on Carotid Endarterectomy and Carotid Artery Stenting Outcomes -- 8 Vertebral Artery Stenting -- 9 Aortic Arch Debranchingfor TEVAR: Open Surgical Options -- 10 Aortic Arch Debranchingfor TEVAR: EndovascularOptions -- Section III Lower Extremity Arterial Disease -- 11 Technical Tips to Improve Outcomes of Distal Lower Extremity Bypass Surgery -- 12 Hybrid Approachesfor Ilio-femoral Arterial Occlusive Disease -- 13 Sutureless Anastomosis in Femoral-Popliteal Bypass for Lower Extremity Revascularization -- 14 Update on Clinical Trials Evaluating the Effect of Biologic Therapy in Patients with Critical Limb Ischemia -- 15 Liquid Cast Arterial Stents: Stents of the Future -- Section IV Lower Extremity Venous Disease -- 16 Management of Venous Trauma: Civilian and Military Injuries -- 17 Iatrogenic Venous Injuries -- 18 Common Femoral Endovenectomy for Postthrombotic Syndrome -- 19 Isolated Distal Deep Venous Thrombosis -- 20 Algorithm for Bulging Varicose Veins -- 21 Practical Approaches toType II Endoleaks After EVAR -- 22 Next Generation Abdominal Endografts:Clinical Context and Devices -- 23 EVAR Explants Definitive Remediation -- 24 Perigraft Seromas Following Open Aortic Reconstruction -- 25 Aortic Surgery and Interventions in Patients with Connective Tissue Disorders.Section VI Visceral and Renal Artery Disease -- 26 Visceral Artery Reconstruction -- 27 In Situ Renal Artery Aneurysm Repair -- 28 Open Surgical Treatment of Mesenteric Occlusive Disease -- 29 Contemporary Management of Acute Type B Aortic Dissection -- Section VII Thoracic Aortic Disease -- 30 Acute Type B Dissections: Open Surgical Options -- 31 Endovascular Management of Type B Aortic Dissections -- 32 Simultaneous TEVAR and EVAR -- 33 Endovascular Repair of Mycotic Thoracic Aortic Aneurysms and Fistulas -- 34 Management of Late TEVAR Failures -- Section VIII Thoracoabdominal Disease -- 35 Disease Progression After Surgery for Takayasu Arteritis -- 36 Hybrid Endovascular Repair of Thoracic and Thoracoabdominal Aortic Aneurysms -- 37 Chimney, Snorkel,Periscope Combined with EVAR/TEVAR -- 38 Branched and Fenestrated TEVAR for Thoracoabdominal Disease -- 39 Spinal Cord Protection After Open Thoracoabdominal Aortic Aneurysm Repair -- 40 Technical Tips for Renal Cell Cancer Caval Tumor Thrombus Removal -- Index.Current Vascualr Surgery 2012 covers the full spectrum of vascualr surgery and includes changes in management of extracranial cerebrovascular disease, new treatment options for lower extremity arterial occlusive disease, novel techniques for complex venous disease, as well as recent cutting-edge developments in aortic stent graft repair in the chest and abdomen., and much more. Current Vascular Surgery 2012 is sponsored by the Division of Vascular Surgery at the Feinberg School of Medicine, Northwestern University in Chicago, Illinois and is part of the Moden Trends in Vascular Surgery series. Modern trends in Vascular Surgery series brings together the best, current strategies for therapeutic and clinical practices. KEY FEATURES * Examines the treatment options for areas of vascular surgery * Provides the latest information on treatment for all modalities * Describes assessment and treatment approaches * Summarizes the advancements in the treatmentVascular Surgical ProceduresmethodsMinimally Invasive Surgical ProceduresmethodsVascular DiseasessurgeryVascular Surgical Proceduresmethods.Minimally Invasive Surgical Proceduresmethods.Vascular Diseasessurgery.617.4/13Eskandari Mark K.Yao James S. T.Pearce William H.PQKBBOOK9910973919003321Current vascular surgery 20124471747UNINA